10-Q Filing

SWK Holdings Corp CIK: 1089907 Q1 2024

Filing Information

Form Type	10-Q
Accession Number	`0001552781-24-000343`
Period End Date	20240331
Filing Date	20240515
Fiscal Year	2024
Fiscal Period	Q1
XBRL Instance	e24218_swkh-10q_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 152 Income Statement 84 Cash Flow Statement 128 Stockholders Equity 34

Balance Sheet 152 line items

Line Item	Tag	Value	Unit	Period
Financing Receivable, Allowance for Credit Loss	`FinancingReceivableAllowanceForCreditLosses`	$11.85M	USD	Point-in-time
Financing Receivable, Allowance for Credit Loss	`FinancingReceivableAllowanceForCreditLosses`	$11.85M	USD	Point-in-time
Financing Receivable, Allowance for Credit Loss	`FinancingReceivableAllowanceForCreditLosses`	$13.90M	USD	Point-in-time
Financing Receivable, Allowance for Credit Loss	`FinancingReceivableAllowanceForCreditLosses`	$13.90M	USD	Point-in-time
Financing Receivable, Allowance for Credit Loss	`FinancingReceivableAllowanceForCreditLosses`	$11.79M	USD	Point-in-time
Financing Receivable, Allowance for Credit Loss	`FinancingReceivableAllowanceForCreditLosses`	$11.79M	USD	Point-in-time
Financing Receivable, Allowance for Credit Loss	`FinancingReceivableAllowanceForCreditLosses`	$13.22M	USD	Point-in-time
Financing Receivable, Allowance for Credit Loss	`FinancingReceivableAllowanceForCreditLosses`	$13.22M	USD	Point-in-time
Preferred Stock, Par or Stated Value Per Share	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred Stock, Par or Stated Value Per Share	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred Stock, Par or Stated Value Per Share	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred Stock, Par or Stated Value Per Share	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred Stock, Shares Authorized	`PreferredStockSharesAuthorized`	5.00M	shares	Point-in-time
Preferred Stock, Shares Authorized	`PreferredStockSharesAuthorized`	5.00M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$4.50M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$4.50M	USD	Point-in-time
Preferred Stock, Shares Authorized	`PreferredStockSharesAuthorized`	5.00M	shares	Point-in-time
Preferred Stock, Shares Authorized	`PreferredStockSharesAuthorized`	5.00M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$5.50M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$5.50M	USD	Point-in-time
Restricted cash	`RestrictedCashEquivalentsCurrent`	-	USD	Point-in-time
Restricted cash	`RestrictedCashEquivalentsCurrent`	-	USD	Point-in-time
Restricted cash	`RestrictedCashEquivalentsCurrent`	$733.00K	USD	Point-in-time
Restricted cash	`RestrictedCashEquivalentsCurrent`	$733.00K	USD	Point-in-time
Preferred Stock, Shares Issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred Stock, Shares Issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred Stock, Shares Issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred Stock, Shares Issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Interest, accounts receivable and other receivables, net	`AccountsReceivableNet`	$6.35M	USD	Point-in-time
Interest, accounts receivable and other receivables, net	`AccountsReceivableNet`	$6.35M	USD	Point-in-time
Interest, accounts receivable and other receivables, net	`AccountsReceivableNet`	$4.73M	USD	Point-in-time
Interest, accounts receivable and other receivables, net	`AccountsReceivableNet`	$4.73M	USD	Point-in-time
Preferred Stock, Shares Outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Preferred Stock, Shares Outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Preferred Stock, Shares Outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Preferred Stock, Shares Outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Common Stock, Par or Stated Value Per Share	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common Stock, Par or Stated Value Per Share	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common Stock, Par or Stated Value Per Share	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common Stock, Par or Stated Value Per Share	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$1.90M	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$1.90M	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$2.09M	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$2.09M	USD	Point-in-time
Common Stock, Shares Authorized	`CommonStockSharesAuthorized`	250.00M	shares	Point-in-time
Common Stock, Shares Authorized	`CommonStockSharesAuthorized`	250.00M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$11.87M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$11.87M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$13.94M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$13.94M	USD	Point-in-time
Common Stock, Shares Authorized	`CommonStockSharesAuthorized`	250.00M	shares	Point-in-time
Common Stock, Shares Authorized	`CommonStockSharesAuthorized`	250.00M	shares	Point-in-time
Finance receivables, net of allowance for credit losses of $13,224 and $13,901 as of March 31, 2024 and December 31, 2023, respectively	`NotesAndLoansReceivableNetCurrent`	$261.29M	USD	Point-in-time
Finance receivables, net of allowance for credit losses of $13,224 and $13,901 as of March 31, 2024 and December 31, 2023, respectively	`NotesAndLoansReceivableNetCurrent`	$261.29M	USD	Point-in-time
Finance receivables, net of allowance for credit losses of $13,224 and $13,901 as of March 31, 2024 and December 31, 2023, respectively	`NotesAndLoansReceivableNetCurrent`	$274.50M	USD	Point-in-time
Finance receivables, net of allowance for credit losses of $13,224 and $13,901 as of March 31, 2024 and December 31, 2023, respectively	`NotesAndLoansReceivableNetCurrent`	$274.50M	USD	Point-in-time
Common Stock, Shares, Issued	`CommonStockSharesIssued`	12.50M	shares	Point-in-time
Common Stock, Shares, Issued	`CommonStockSharesIssued`	12.50M	shares	Point-in-time
Common Stock, Shares, Issued	`CommonStockSharesIssued`	12.48M	shares	Point-in-time
Common Stock, Shares, Issued	`CommonStockSharesIssued`	12.48M	shares	Point-in-time
Common Stock, Shares, Outstanding	`CommonStockSharesOutstanding`	12.50M	shares	Point-in-time
Common Stock, Shares, Outstanding	`CommonStockSharesOutstanding`	12.50M	shares	Point-in-time
Collateral on foreign currency forward contract	`DerivativeInstrumentsAndHedges`	$2.75M	USD	Point-in-time
Collateral on foreign currency forward contract	`DerivativeInstrumentsAndHedges`	$2.75M	USD	Point-in-time
Collateral on foreign currency forward contract	`DerivativeInstrumentsAndHedges`	$2.75M	USD	Point-in-time
Collateral on foreign currency forward contract	`DerivativeInstrumentsAndHedges`	$2.75M	USD	Point-in-time
Common Stock, Shares, Outstanding	`CommonStockSharesOutstanding`	12.48M	shares	Point-in-time
Common Stock, Shares, Outstanding	`CommonStockSharesOutstanding`	12.48M	shares	Point-in-time
Marketable investments	`AvailableForSaleSecuritiesDebtSecurities`	$394.00K	USD	Point-in-time
Marketable investments	`AvailableForSaleSecuritiesDebtSecurities`	$394.00K	USD	Point-in-time
Marketable investments	`AvailableForSaleSecuritiesDebtSecurities`	$48.00K	USD	Point-in-time
Marketable investments	`AvailableForSaleSecuritiesDebtSecurities`	$48.00K	USD	Point-in-time
Deferred tax assets, net	`DeferredIncomeTaxAssetsNet`	$28.08M	USD	Point-in-time
Deferred tax assets, net	`DeferredIncomeTaxAssetsNet`	$28.08M	USD	Point-in-time
Deferred tax assets, net	`DeferredIncomeTaxAssetsNet`	$28.29M	USD	Point-in-time
Deferred tax assets, net	`DeferredIncomeTaxAssetsNet`	$28.29M	USD	Point-in-time
Warrant assets	`WarrantAssets`	$610.00K	USD	Point-in-time
Warrant assets	`WarrantAssets`	$610.00K	USD	Point-in-time
Warrant assets	`WarrantAssets`	$1.76M	USD	Point-in-time
Warrant assets	`WarrantAssets`	$1.76M	USD	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$6.20M	USD	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$6.20M	USD	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$6.49M	USD	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$6.49M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$5.44M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$5.44M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$5.21M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$5.21M	USD	Point-in-time
Other non-current assets	`OtherAssetsNoncurrent`	$3.89M	USD	Point-in-time
Other non-current assets	`OtherAssetsNoncurrent`	$3.89M	USD	Point-in-time
Other non-current assets	`OtherAssetsNoncurrent`	$3.11M	USD	Point-in-time
Other non-current assets	`OtherAssetsNoncurrent`	$3.11M	USD	Point-in-time
Total assets	`Assets`	$322.35M	USD	Point-in-time
Total assets	`Assets`	$322.35M	USD	Point-in-time
Total assets	`Assets`	$334.25M	USD	Point-in-time
Total assets	`Assets`	$334.25M	USD	Point-in-time
Accounts payable and accrued liabilities	`AccountsPayableAndAccruedLiabilitiesCurrent`	$4.38M	USD	Point-in-time
Accounts payable and accrued liabilities	`AccountsPayableAndAccruedLiabilitiesCurrent`	$4.38M	USD	Point-in-time
Accounts payable and accrued liabilities	`AccountsPayableAndAccruedLiabilitiesCurrent`	$3.94M	USD	Point-in-time
Accounts payable and accrued liabilities	`AccountsPayableAndAccruedLiabilitiesCurrent`	$3.94M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$4.38M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$4.38M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$3.94M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$3.94M	USD	Point-in-time
Contingent consideration payable	`ContingentConsiderationClassifiedAsEquityFairValueDisclosure`	$4.90M	USD	Point-in-time
Contingent consideration payable	`ContingentConsiderationClassifiedAsEquityFairValueDisclosure`	$4.90M	USD	Point-in-time
Contingent consideration payable	`ContingentConsiderationClassifiedAsEquityFairValueDisclosure`	$4.90M	USD	Point-in-time
Contingent consideration payable	`ContingentConsiderationClassifiedAsEquityFairValueDisclosure`	$4.90M	USD	Point-in-time
Unsecured senior notes, net	`UnsecuredDebt`	$30.78M	USD	Point-in-time
Unsecured senior notes, net	`UnsecuredDebt`	$30.78M	USD	Point-in-time
Unsecured senior notes, net	`UnsecuredDebt`	$30.93M	USD	Point-in-time
Unsecured senior notes, net	`UnsecuredDebt`	$30.93M	USD	Point-in-time
Revolving credit facility	`LongTermLineOfCredit`	-	USD	Point-in-time
Revolving credit facility	`LongTermLineOfCredit`	-	USD	Point-in-time
Revolving credit facility	`LongTermLineOfCredit`	$12.35M	USD	Point-in-time
Revolving credit facility	`LongTermLineOfCredit`	$12.35M	USD	Point-in-time
Other non-current liabilities	`OtherLiabilitiesNoncurrent`	$1.96M	USD	Point-in-time
Other non-current liabilities	`OtherLiabilitiesNoncurrent`	$1.96M	USD	Point-in-time
Other non-current liabilities	`OtherLiabilitiesNoncurrent`	$1.86M	USD	Point-in-time
Other non-current liabilities	`OtherLiabilitiesNoncurrent`	$1.86M	USD	Point-in-time
Total liabilities	`Liabilities`	$53.94M	USD	Point-in-time
Total liabilities	`Liabilities`	$53.94M	USD	Point-in-time
Total liabilities	`Liabilities`	$42.06M	USD	Point-in-time
Total liabilities	`Liabilities`	$42.06M	USD	Point-in-time
Preferred stock, $0.001 par value; 5,000,000 shares authorized; no shares issued and outstanding	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, $0.001 par value; 5,000,000 shares authorized; no shares issued and outstanding	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, $0.001 par value; 5,000,000 shares authorized; no shares issued and outstanding	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, $0.001 par value; 5,000,000 shares authorized; no shares issued and outstanding	`PreferredStockValue`	-	USD	Point-in-time
Common stock, $0.001 par value; 250,000,000 shares authorized; 12,481,944 and 12,497,770 shares issued and outstanding as of March 31, 2024 and December 31, 2023, respectively	`CommonStockValue`	$12.00K	USD	Point-in-time
Common stock, $0.001 par value; 250,000,000 shares authorized; 12,481,944 and 12,497,770 shares issued and outstanding as of March 31, 2024 and December 31, 2023, respectively	`CommonStockValue`	$12.00K	USD	Point-in-time
Common stock, $0.001 par value; 250,000,000 shares authorized; 12,481,944 and 12,497,770 shares issued and outstanding as of March 31, 2024 and December 31, 2023, respectively	`CommonStockValue`	$12.00K	USD	Point-in-time
Common stock, $0.001 par value; 250,000,000 shares authorized; 12,481,944 and 12,497,770 shares issued and outstanding as of March 31, 2024 and December 31, 2023, respectively	`CommonStockValue`	$12.00K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$4.42B	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$4.42B	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$4.43B	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$4.43B	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-4.14B	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-4.14B	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-4.14B	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-4.14B	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$279.93M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$279.93M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$280.29M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$280.29M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$280.31M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$280.31M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$274.38M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$274.38M	USD	Point-in-time
Total liabilities and stockholders equity	`LiabilitiesAndStockholdersEquity`	$322.35M	USD	Point-in-time
Total liabilities and stockholders equity	`LiabilitiesAndStockholdersEquity`	$322.35M	USD	Point-in-time
Total liabilities and stockholders equity	`LiabilitiesAndStockholdersEquity`	$334.25M	USD	Point-in-time
Total liabilities and stockholders equity	`LiabilitiesAndStockholdersEquity`	$334.25M	USD	Point-in-time

Income Statement 84 line items

Line Item	Tag	Value	Unit	Period
Finance receivable interest income, including fees	`InterestAndFeeIncomeLoansAndLeases`	$9.26M	USD	1 Quarter
Finance receivable interest income, including fees	`InterestAndFeeIncomeLoansAndLeases`	$9.26M	USD	1 Quarter
Finance receivable interest income, including fees	`InterestAndFeeIncomeLoansAndLeases`	$11.45M	USD	1 Quarter
Finance receivable interest income, including fees	`InterestAndFeeIncomeLoansAndLeases`	$11.45M	USD	1 Quarter
Pharmaceutical development	`PharmaceuticalDevelopmentRevenue`	$279.00K	USD	1 Quarter
Pharmaceutical development	`PharmaceuticalDevelopmentRevenue`	$279.00K	USD	1 Quarter
Pharmaceutical development	`PharmaceuticalDevelopmentRevenue`	$118.00K	USD	1 Quarter
Pharmaceutical development	`PharmaceuticalDevelopmentRevenue`	$118.00K	USD	1 Quarter
Other	`RevenueNotFromContractWithCustomerOther`	$46.00K	USD	1 Quarter
Other	`RevenueNotFromContractWithCustomerOther`	$46.00K	USD	1 Quarter
Other	`RevenueNotFromContractWithCustomerOther`	$33.00K	USD	1 Quarter
Other	`RevenueNotFromContractWithCustomerOther`	$33.00K	USD	1 Quarter
Total revenues	`Revenues`	$11.78M	USD	1 Quarter
Total revenues	`Revenues`	$11.78M	USD	1 Quarter
Total revenues	`Revenues`	$9.41M	USD	1 Quarter
Total revenues	`Revenues`	$9.41M	USD	1 Quarter
Provision for credit losses	`ProvisionForOtherCreditLosses`	-	USD	1 Quarter
Provision for credit losses	`ProvisionForOtherCreditLosses`	-	USD	1 Quarter
Provision for credit losses	`ProvisionForOtherCreditLosses`	$5.32M	USD	1 Quarter
Provision for credit losses	`ProvisionForOtherCreditLosses`	$5.32M	USD	1 Quarter
Interest expense	`InterestExpense`	$182.00K	USD	1 Quarter
Interest expense	`InterestExpense`	$182.00K	USD	1 Quarter
Interest expense	`InterestExpense`	$1.26M	USD	1 Quarter
Interest expense	`InterestExpense`	$1.26M	USD	1 Quarter
Pharmaceutical manufacturing, research and development expense	`ResearchAndDevelopmentExpense`	$530.00K	USD	1 Quarter
Pharmaceutical manufacturing, research and development expense	`ResearchAndDevelopmentExpense`	$530.00K	USD	1 Quarter
Pharmaceutical manufacturing, research and development expense	`ResearchAndDevelopmentExpense`	$719.00K	USD	1 Quarter
Pharmaceutical manufacturing, research and development expense	`ResearchAndDevelopmentExpense`	$719.00K	USD	1 Quarter
Depreciation and amortization expense	`DepreciationAndAmortization`	$648.00K	USD	1 Quarter
Depreciation and amortization expense	`DepreciationAndAmortization`	$648.00K	USD	1 Quarter
Depreciation and amortization expense	`DepreciationAndAmortization`	$514.00K	USD	1 Quarter
Depreciation and amortization expense	`DepreciationAndAmortization`	$514.00K	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$2.54M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$2.54M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$2.68M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$2.68M	USD	1 Quarter
Income from operations	`CostsAndExpenses`	$-5.32M	USD	1 Quarter
Income from operations	`CostsAndExpenses`	$-5.32M	USD	1 Quarter
Income from operations	`CostsAndExpenses`	$-1.47M	USD	1 Quarter
Income from operations	`CostsAndExpenses`	$-1.47M	USD	1 Quarter
Unrealized net loss on warrants	`UnrealizedGainLossOnDerivatives`	$-982.00K	USD	1 Quarter
Unrealized net loss on warrants	`UnrealizedGainLossOnDerivatives`	$-982.00K	USD	1 Quarter
Unrealized net loss on warrants	`UnrealizedGainLossOnDerivatives`	$-95.00K	USD	1 Quarter
Unrealized net loss on warrants	`UnrealizedGainLossOnDerivatives`	$-95.00K	USD	1 Quarter
Loss on exercise of warrants	`LossOnExerciseOfWarrant`	$-143.00K	USD	1 Quarter
Loss on exercise of warrants	`LossOnExerciseOfWarrant`	$-143.00K	USD	1 Quarter
Loss on exercise of warrants	`LossOnExerciseOfWarrant`	-	USD	1 Quarter
Loss on exercise of warrants	`LossOnExerciseOfWarrant`	-	USD	1 Quarter
Realized loss on sale of marketable investments	`MarketableSecuritiesRealizedGainLoss`	-	USD	1 Quarter
Realized loss on sale of marketable investments	`MarketableSecuritiesRealizedGainLoss`	-	USD	1 Quarter
Realized loss on sale of marketable investments	`MarketableSecuritiesRealizedGainLoss`	$-231.00K	USD	1 Quarter
Realized loss on sale of marketable investments	`MarketableSecuritiesRealizedGainLoss`	$-231.00K	USD	1 Quarter
Gain on foreign currency transactions	`ForeignCurrencyTransactionGainBeforeTax`	$186.00K	USD	1 Quarter
Gain on foreign currency transactions	`ForeignCurrencyTransactionGainBeforeTax`	$186.00K	USD	1 Quarter
Gain on foreign currency transactions	`ForeignCurrencyTransactionGainBeforeTax`	$87.00K	USD	1 Quarter
Gain on foreign currency transactions	`ForeignCurrencyTransactionGainBeforeTax`	$87.00K	USD	1 Quarter
Income before income tax expense (benefit)	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$4.53M	USD	1 Quarter
Income before income tax expense (benefit)	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$4.53M	USD	1 Quarter
Income before income tax expense (benefit)	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$1.09M	USD	1 Quarter
Income before income tax expense (benefit)	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$1.09M	USD	1 Quarter
Income tax expense (benefit)	`IncomeTaxExpenseBenefit`	$-109.00K	USD	1 Quarter
Income tax expense (benefit)	`IncomeTaxExpenseBenefit`	$-109.00K	USD	1 Quarter
Income tax expense (benefit)	`IncomeTaxExpenseBenefit`	$229.00K	USD	1 Quarter
Income tax expense (benefit)	`IncomeTaxExpenseBenefit`	$229.00K	USD	1 Quarter
Net income	`ProfitLoss`	$861.00K	USD	1 Quarter
Net income	`ProfitLoss`	$861.00K	USD	1 Quarter
Net income	`ProfitLoss`	$4.63M	USD	1 Quarter
Net income	`ProfitLoss`	$4.63M	USD	1 Quarter
Basic	`EarningsPerShareBasic`	$0.07	USD	1 Quarter
Basic	`EarningsPerShareBasic`	$0.07	USD	1 Quarter
Basic	`EarningsPerShareBasic`	$0.36	USD	1 Quarter
Basic	`EarningsPerShareBasic`	$0.36	USD	1 Quarter
Diluted	`EarningsPerShareDiluted`	$0.36	USD	1 Quarter
Diluted	`EarningsPerShareDiluted`	$0.36	USD	1 Quarter
Diluted	`EarningsPerShareDiluted`	$0.07	USD	1 Quarter
Diluted	`EarningsPerShareDiluted`	$0.07	USD	1 Quarter
Basic	`WeightedAverageNumberOfSharesOutstandingBasic`	12.83M	shares	1 Quarter
Basic	`WeightedAverageNumberOfSharesOutstandingBasic`	12.83M	shares	1 Quarter
Basic	`WeightedAverageNumberOfSharesOutstandingBasic`	12.47M	shares	1 Quarter
Basic	`WeightedAverageNumberOfSharesOutstandingBasic`	12.47M	shares	1 Quarter
Diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	12.88M	shares	1 Quarter
Diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	12.88M	shares	1 Quarter
Diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	12.54M	shares	1 Quarter
Diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	12.54M	shares	1 Quarter

Cash Flow Statement 128 line items

Line Item	Tag	Value	Unit	Period
Net income	`ProfitLoss`	$861.00K	USD	1 Quarter
Net income	`ProfitLoss`	$861.00K	USD	1 Quarter
Net income	`ProfitLoss`	$4.63M	USD	1 Quarter
Net income	`ProfitLoss`	$4.63M	USD	1 Quarter
Provision for credit losses	`ProvisionForOtherCreditLosses`	-	USD	1 Quarter
Provision for credit losses	`ProvisionForOtherCreditLosses`	-	USD	1 Quarter
Provision for credit losses	`ProvisionForOtherCreditLosses`	$5.32M	USD	1 Quarter
Provision for credit losses	`ProvisionForOtherCreditLosses`	$5.32M	USD	1 Quarter
Right-of-use asset amortization	`FinanceLeaseRightOfUseAssetAmortization`	$91.00K	USD	1 Quarter
Right-of-use asset amortization	`FinanceLeaseRightOfUseAssetAmortization`	$91.00K	USD	1 Quarter
Right-of-use asset amortization	`FinanceLeaseRightOfUseAssetAmortization`	$68.00K	USD	1 Quarter
Right-of-use asset amortization	`FinanceLeaseRightOfUseAssetAmortization`	$68.00K	USD	1 Quarter
Amortization of debt issuance costs	`NoncashInterestExpense`	$15.00K	USD	1 Quarter
Amortization of debt issuance costs	`NoncashInterestExpense`	$15.00K	USD	1 Quarter
Amortization of debt issuance costs	`NoncashInterestExpense`	$248.00K	USD	1 Quarter
Amortization of debt issuance costs	`NoncashInterestExpense`	$248.00K	USD	1 Quarter
Deferred income taxes	`DeferredIncomeTaxesAndTaxCredits`	$-122.00K	USD	1 Quarter
Deferred income taxes	`DeferredIncomeTaxesAndTaxCredits`	$-122.00K	USD	1 Quarter
Deferred income taxes	`DeferredIncomeTaxesAndTaxCredits`	$229.00K	USD	1 Quarter
Deferred income taxes	`DeferredIncomeTaxesAndTaxCredits`	$229.00K	USD	1 Quarter
Change in fair value of warrants	`FairValueAdjustmentOfWarrants`	$982.00K	USD	1 Quarter
Change in fair value of warrants	`FairValueAdjustmentOfWarrants`	$982.00K	USD	1 Quarter
Change in fair value of warrants	`FairValueAdjustmentOfWarrants`	$95.00K	USD	1 Quarter
Change in fair value of warrants	`FairValueAdjustmentOfWarrants`	$95.00K	USD	1 Quarter
Loss on exercise of warrants	`LossOnExerciseOfWarrant`	$-143.00K	USD	1 Quarter
Loss on exercise of warrants	`LossOnExerciseOfWarrant`	$-143.00K	USD	1 Quarter
Loss on exercise of warrants	`LossOnExerciseOfWarrant`	-	USD	1 Quarter
Loss on exercise of warrants	`LossOnExerciseOfWarrant`	-	USD	1 Quarter
Foreign currency transaction (gain) loss	`ChangeInFairValueOfDerivativeLiability`	$186.00K	USD	1 Quarter
Foreign currency transaction (gain) loss	`ChangeInFairValueOfDerivativeLiability`	$186.00K	USD	1 Quarter
Foreign currency transaction (gain) loss	`ChangeInFairValueOfDerivativeLiability`	$-918.00K	USD	1 Quarter
Foreign currency transaction (gain) loss	`ChangeInFairValueOfDerivativeLiability`	$-918.00K	USD	1 Quarter
Realized loss on sale of marketable investments	`MarketableSecuritiesRealizedGainLoss`	-	USD	1 Quarter
Realized loss on sale of marketable investments	`MarketableSecuritiesRealizedGainLoss`	-	USD	1 Quarter
Realized loss on sale of marketable investments	`MarketableSecuritiesRealizedGainLoss`	$-231.00K	USD	1 Quarter
Realized loss on sale of marketable investments	`MarketableSecuritiesRealizedGainLoss`	$-231.00K	USD	1 Quarter
Loan discount and fee accretion on finance receivables	`AmortizationOfDeferredLoanOriginationFeesNet`	$1.47M	USD	1 Quarter
Loan discount and fee accretion on finance receivables	`AmortizationOfDeferredLoanOriginationFeesNet`	$1.47M	USD	1 Quarter
Loan discount and fee accretion on finance receivables	`AmortizationOfDeferredLoanOriginationFeesNet`	$1.26M	USD	1 Quarter
Loan discount and fee accretion on finance receivables	`AmortizationOfDeferredLoanOriginationFeesNet`	$1.26M	USD	1 Quarter
Interest paid-in-kind	`PaidInKindInterest`	$478.00K	USD	1 Quarter
Interest paid-in-kind	`PaidInKindInterest`	$478.00K	USD	1 Quarter
Interest paid-in-kind	`PaidInKindInterest`	$351.00K	USD	1 Quarter
Interest paid-in-kind	`PaidInKindInterest`	$351.00K	USD	1 Quarter
Stock-based compensation	`ShareBasedCompensation`	$35.00K	USD	1 Quarter
Stock-based compensation	`ShareBasedCompensation`	$35.00K	USD	1 Quarter
Stock-based compensation	`ShareBasedCompensation`	$111.00K	USD	1 Quarter
Stock-based compensation	`ShareBasedCompensation`	$111.00K	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$514.00K	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$514.00K	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$648.00K	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$648.00K	USD	1 Quarter
Interest, accounts, and other receivables	`IncreaseDecreaseInInterestAndDividendsReceivable`	$-1.25M	USD	1 Quarter
Interest, accounts, and other receivables	`IncreaseDecreaseInInterestAndDividendsReceivable`	$-1.25M	USD	1 Quarter
Interest, accounts, and other receivables	`IncreaseDecreaseInInterestAndDividendsReceivable`	$-1.62M	USD	1 Quarter
Interest, accounts, and other receivables	`IncreaseDecreaseInInterestAndDividendsReceivable`	$-1.62M	USD	1 Quarter
Derivative assets and liabilities, net	`DerivativeInstrumentReceivable`	$-388.00K	USD	1 Quarter
Derivative assets and liabilities, net	`DerivativeInstrumentReceivable`	$-388.00K	USD	1 Quarter
Derivative assets and liabilities, net	`DerivativeInstrumentReceivable`	$831.00K	USD	1 Quarter
Derivative assets and liabilities, net	`DerivativeInstrumentReceivable`	$831.00K	USD	1 Quarter
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$915.00K	USD	1 Quarter
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$915.00K	USD	1 Quarter
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$283.00K	USD	1 Quarter
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$283.00K	USD	1 Quarter
Accounts payable and other liabilities	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$-1.41M	USD	1 Quarter
Accounts payable and other liabilities	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$-1.41M	USD	1 Quarter
Accounts payable and other liabilities	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$311.00K	USD	1 Quarter
Accounts payable and other liabilities	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$311.00K	USD	1 Quarter
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$664.00K	USD	1 Quarter
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$664.00K	USD	1 Quarter
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$4.43M	USD	1 Quarter
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$4.43M	USD	1 Quarter
Sale of marketable investments	`ProceedsFromSaleOfEquitySecuritiesFvNi`	$258.00K	USD	1 Quarter
Sale of marketable investments	`ProceedsFromSaleOfEquitySecuritiesFvNi`	$258.00K	USD	1 Quarter
Sale of marketable investments	`ProceedsFromSaleOfEquitySecuritiesFvNi`	-	USD	1 Quarter
Sale of marketable investments	`ProceedsFromSaleOfEquitySecuritiesFvNi`	-	USD	1 Quarter
Investment in finance receivables	`PaymentsToAcquireFinanceReceivables`	$12.99M	USD	1 Quarter
Investment in finance receivables	`PaymentsToAcquireFinanceReceivables`	$12.99M	USD	1 Quarter
Investment in finance receivables	`PaymentsToAcquireFinanceReceivables`	$446.00K	USD	1 Quarter
Investment in finance receivables	`PaymentsToAcquireFinanceReceivables`	$446.00K	USD	1 Quarter
Repayment of finance receivables	`ProceedsRepaymentOfFinanceReceivables`	$1.91M	USD	1 Quarter
Repayment of finance receivables	`ProceedsRepaymentOfFinanceReceivables`	$1.91M	USD	1 Quarter
Repayment of finance receivables	`ProceedsRepaymentOfFinanceReceivables`	$9.36M	USD	1 Quarter
Repayment of finance receivables	`ProceedsRepaymentOfFinanceReceivables`	$9.36M	USD	1 Quarter
Corporate debt securities principal payments	`MarketableInvestmentPrincipalPayment`	$10.00K	USD	1 Quarter
Corporate debt securities principal payments	`MarketableInvestmentPrincipalPayment`	$10.00K	USD	1 Quarter
Corporate debt securities principal payments	`MarketableInvestmentPrincipalPayment`	$7.00K	USD	1 Quarter
Corporate debt securities principal payments	`MarketableInvestmentPrincipalPayment`	$7.00K	USD	1 Quarter
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	-	USD	1 Quarter
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	-	USD	1 Quarter
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$8.00K	USD	1 Quarter
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$8.00K	USD	1 Quarter
Net cash provided by (used in) investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-11.08M	USD	1 Quarter
Net cash provided by (used in) investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-11.08M	USD	1 Quarter
Net cash provided by (used in) investing activities	`NetCashProvidedByUsedInInvestingActivities`	$9.18M	USD	1 Quarter
Net cash provided by (used in) investing activities	`NetCashProvidedByUsedInInvestingActivities`	$9.18M	USD	1 Quarter
Net (payments on) proceeds from credit facility	`ProceedsFromRepaymentsOfLinesOfCredit`	$8.04M	USD	1 Quarter
Net (payments on) proceeds from credit facility	`ProceedsFromRepaymentsOfLinesOfCredit`	$8.04M	USD	1 Quarter
Net (payments on) proceeds from credit facility	`ProceedsFromRepaymentsOfLinesOfCredit`	$-12.35M	USD	1 Quarter
Net (payments on) proceeds from credit facility	`ProceedsFromRepaymentsOfLinesOfCredit`	$-12.35M	USD	1 Quarter
Repurchases of common stock, including fees and expenses	`PaymentsForRepurchaseOfCommonStock`	$531.00K	USD	1 Quarter
Repurchases of common stock, including fees and expenses	`PaymentsForRepurchaseOfCommonStock`	$531.00K	USD	1 Quarter
Repurchases of common stock, including fees and expenses	`PaymentsForRepurchaseOfCommonStock`	$999.00K	USD	1 Quarter
Repurchases of common stock, including fees and expenses	`PaymentsForRepurchaseOfCommonStock`	$999.00K	USD	1 Quarter
Net cash (used in) provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-13.35M	USD	1 Quarter
Net cash (used in) provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-13.35M	USD	1 Quarter
Net cash (used in) provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$7.51M	USD	1 Quarter
Net cash (used in) provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$7.51M	USD	1 Quarter
Net increase (decrease) in cash, cash equivalents, and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-2.91M	USD	1 Quarter
Net increase (decrease) in cash, cash equivalents, and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-2.91M	USD	1 Quarter
Net increase (decrease) in cash, cash equivalents, and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$262.00K	USD	1 Quarter
Net increase (decrease) in cash, cash equivalents, and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$262.00K	USD	1 Quarter
Cash, cash equivalents, and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$5.24M	USD	Point-in-time
Cash, cash equivalents, and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$5.24M	USD	Point-in-time
Cash, cash equivalents, and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$3.24M	USD	Point-in-time
Cash, cash equivalents, and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$3.24M	USD	Point-in-time
Cash, cash equivalents, and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$5.50M	USD	Point-in-time
Cash, cash equivalents, and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$5.50M	USD	Point-in-time
Cash, cash equivalents, and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$6.16M	USD	Point-in-time
Cash, cash equivalents, and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$6.16M	USD	Point-in-time
Cash, cash equivalents, and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$5.24M	USD	Point-in-time
Cash, cash equivalents, and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$5.24M	USD	Point-in-time
Cash, cash equivalents, and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$3.24M	USD	Point-in-time
Cash, cash equivalents, and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$3.24M	USD	Point-in-time
Cash, cash equivalents, and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$5.50M	USD	Point-in-time
Cash, cash equivalents, and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$5.50M	USD	Point-in-time
Cash, cash equivalents, and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$6.16M	USD	Point-in-time
Cash, cash equivalents, and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$6.16M	USD	Point-in-time

Stockholders Equity 34 line items

Line Item	Tag	Value	Unit	Period
Beginning balance, value	`StockholdersEquity`	$279.93M	USD	Point-in-time
Beginning balance, value	`StockholdersEquity`	$279.93M	USD	Point-in-time
Beginning balance, value	`StockholdersEquity`	$280.29M	USD	Point-in-time
Beginning balance, value	`StockholdersEquity`	$280.29M	USD	Point-in-time
Beginning balance, value	`StockholdersEquity`	$280.31M	USD	Point-in-time
Beginning balance, value	`StockholdersEquity`	$280.31M	USD	Point-in-time
Beginning balance, value	`StockholdersEquity`	$274.38M	USD	Point-in-time
Beginning balance, value	`StockholdersEquity`	$274.38M	USD	Point-in-time
Stock-based compensation	`ShareBasedCompensation`	$35.00K	USD	1 Quarter
Stock-based compensation	`ShareBasedCompensation`	$35.00K	USD	1 Quarter
Stock-based compensation	`ShareBasedCompensation`	$111.00K	USD	1 Quarter
Stock-based compensation	`ShareBasedCompensation`	$111.00K	USD	1 Quarter
Issuance of common stock upon vesting of restricted stock	`StockIssuedDuringPeriodValueNewIssues`	-	USD	1 Quarter
Issuance of common stock upon vesting of restricted stock	`StockIssuedDuringPeriodValueNewIssues`	-	USD	1 Quarter
Issuance of common stock upon vesting of restricted stock	`StockIssuedDuringPeriodValueNewIssues`	-	USD	1 Quarter
Issuance of common stock upon vesting of restricted stock	`StockIssuedDuringPeriodValueNewIssues`	-	USD	1 Quarter
Repurchases of common stock in open market	`StockRepurchasedDuringPeriodValue`	$531.00K	USD	1 Quarter
Repurchases of common stock in open market	`StockRepurchasedDuringPeriodValue`	$531.00K	USD	1 Quarter
Repurchases of common stock in open market	`StockRepurchasedDuringPeriodValue`	$999.00K	USD	1 Quarter
Repurchases of common stock in open market	`StockRepurchasedDuringPeriodValue`	$999.00K	USD	1 Quarter
Net income	`NetIncomeLoss`	$4.63M	USD	1 Quarter
Net income	`NetIncomeLoss`	$4.63M	USD	1 Quarter
Net income	`NetIncomeLoss`	$861.00K	USD	1 Quarter
Net income	`NetIncomeLoss`	$861.00K	USD	1 Quarter
Effect of adoption of ASU 2016-13	`EffectOfAdoptionOfAccountingStandard`	$-9.68M	USD	1 Quarter
Effect of adoption of ASU 2016-13	`EffectOfAdoptionOfAccountingStandard`	$-9.68M	USD	1 Quarter
Ending balance, value	`StockholdersEquity`	$279.93M	USD	Point-in-time
Ending balance, value	`StockholdersEquity`	$279.93M	USD	Point-in-time
Ending balance, value	`StockholdersEquity`	$280.29M	USD	Point-in-time
Ending balance, value	`StockholdersEquity`	$280.29M	USD	Point-in-time
Ending balance, value	`StockholdersEquity`	$280.31M	USD	Point-in-time
Ending balance, value	`StockholdersEquity`	$280.31M	USD	Point-in-time
Ending balance, value	`StockholdersEquity`	$274.38M	USD	Point-in-time
Ending balance, value	`StockholdersEquity`	$274.38M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.